Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Energy Instruments and Stapling Device to Dissect Intersegmental Plane in Segmentectomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 1. Age: 18 to 70 years old; 2. Pulmonary nodules or GGO found in chest CT examination, and conform with indications for segmentectomy mentioned in NCCN guidelines:~  1. Poor pulmonary reserve or other major comorbidity that contraindicates lobectomy;~ 2. Peripheral nodule ≤2 cm with at least one of the following:~  <!-- -->~  1. Pure (Adenocarcinoma in situ) AIS histology;~ 2. Nodule has ≥50% ground-glass appearance on CT;~ 3. Radiologic surveillance confirms a long doubling time (≥400 days). 3. Normal in preoperative tests, such as blood routine examination, liver function, renal function, coagulation function, etc.~  4. ASA score: Grade I-III. 5. Patients who can coordinate the treatment and research and sign the informed consent.~Exclusion Criteria:~* 1. Patients have history of malignant tumor, or have accepted neoadjuvant chemotherapy and(or) radiotherapy.~  2. Patients have comorbidities in cardiovascular, kidney, lung or hematopoietic system, who cannot tolerate the surgery.~  3. Psychiatric patients。 4. Patient have history of chest trauma or surgery on ipsilateral chest.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Energy Instruments Group (Type: EXPERIMENTAL): All enrolled patients will accept robot-assisted or uniportal segmentectomy. After cutting off the relevant segmental arteries and veins, we clamp the segmental bronchus, and then the diseased lung will be ventilated to identify the border of segment according to the collapse region. We use energy instruments dissect intersegmental plane along the determined border. If fast-frozen pathology confirms lung cancer, we will do lymphadenectomy. At last, a drainage tube will be placed.
- Stapling Device Group (Type: EXPERIMENTAL): All enrolled patients will accept robot-assisted or uniportal segmentectomy. After cutting off the relevant segmental arteries and veins, we clamp the segmental bronchus, and then the diseased lung will be ventilated to identify the border of segment according to the collapse region. We use stapling device to dissect intersegmental plane along the determined border. If fast-frozen pathology confirms lung cancer, we will do lymphadenectomy. At last, a drainage tube will be placed.

Based on this trial design, predict the completion outcome and termination type (if applicable).